Living Science

The Baruch S. Blumberg Institute is the nation’s leading translational research organization dedicated to finding a cure for hepatitis B and liver cancer in our lifetime.

The Blumberg Institute supports drug discovery, biomarker discovery and translational biotechnology around common research themes such as chronic hepatitis, liver disease, and liver cancer in an environment conducive to interaction, collaboration and focus.

Upcoming Seminars

  • Regional Biotech Conference

    Friday, November 15, 2019:

    Show Me the Money: Life Science Start-up Fundraising is the theme of the 2019 RBC.

  • International HBV Meeting

    October 1-5, 2019

    The definitive annual meeting that covers all aspects of the biology of hepatitis B and related diseases

  • Research Seminar Schedule:

    We host a distinguished professional Seminar Series to promote scientific exchange at a national and international level. Renowned leaders in the field are invited to speak on a regular schedule, which is free and open to the interested public.

Research Highlights

Leading the Way to a Cure

Over the past year, Blumberg scientists have seen success with compounds moving into clinical trials as well as with basic science discovery. We expect more of our discoveries, and discoveries that we inspire, to reach human trials soon.

Read More


A Research Agenda for Curing Chronic Hepatitis B Virus Infection

A proposed scientific pathway that we believe will lead to the development of curative therapies for chronic HBV infection and its associated diseases.

Read More

Can HIV-Blocking Drugs Enhance Therapy for Breast Cancer?

Research by the Baruch S. Blumberg Institute’s Pennsylvania Cancer and Regenerative Medicine Research Center suggests that the use of HIV drugs can allow for lower doses of chemotherapy in treating breast cancer, reducing side effects...

Read More


Areas of Focus

  • focus5

    Drug Discovery & Medicinal Chemistry

    Discovering new medicines for hepatitis B, liver cancer and other viral diseases through integrated chemical biological approaches. Learn more.

  • focus2

    Biomarker Discovery

    Discovering biomarkers for liver diseases and early, non-invasive diagnosis of cancers. Learn more.

  • focus3

    Viral Pathogenesis

    Exploring the mechanism of hepatitis B virus infection and identifying molecular targets for curative therapeutics.

  • focus4

    Pennsylvania Cancer & Regenerative Medicine Research Center

    Translating discoveries in cancer and regenerative medicine, with a focus on the role of stem cells and metabolism governing these processes. Learn more.

  • public health

    Public Health

    Decreasing the burden of disease and death from hepatitis B and liver cancer by increasing awareness, testing, and linkage to care to prevent and control this serious liver infection. Learn more.

  • focus6

    Academic Programs

    Exceptional educational opportunities that combine rigorous academic learning, practical experience, and the use of advanced technologies, for students at every level. Learn more.